SRZN
Price:
$9.2326
Market Cap:
$29.60M
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Sur...[Read more]
Industry
Biotechnology
IPO Date
2021-01-11
Stock Exchange
NASDAQ
Ticker
SRZN
According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.96. This represents a change of 10.72% compared to the average of 6.29 of the last 4 quarters.
The mean historical Current Ratio of Surrozen, Inc. over the last ten years is 7.26. The current 6.96 Current Ratio has changed 9.49% with respect to the historical average. Over the past ten years (40 quarters), SRZN's Current Ratio was at its highest in in the March 2022 quarter at 11.79. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
7.26
Median
7.54
Minimum
5.75
Maximum
8.35
Discovering the peaks and valleys of Surrozen, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.30%
Maximum Annual Current Ratio = 8.35
Minimum Annual Increase = -31.12%
Minimum Annual Current Ratio = 5.75
Year | Current Ratio | Change |
---|---|---|
2023 | 5.75 | -31.12% |
2022 | 8.35 | 7.80% |
2021 | 7.75 | 12.30% |
2020 | 6.90 | -8.50% |
The current Current Ratio of Surrozen, Inc. (SRZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.29
5-year avg
7.26
10-year avg
7.26
Surrozen, Inc.’s Current Ratio is greater than Bolt Biotherapeutics, Inc. (4.28), less than Larimar Therapeutics, Inc. (10.93), less than Keros Therapeutics, Inc. (20.37), less than Kezar Life Sciences, Inc. (9.58), greater than Processa Pharmaceuticals, Inc. (4.82), greater than NexImmune, Inc. (0.66), greater than Evelo Biosciences, Inc. (0.48), greater than Tempest Therapeutics, Inc. (2.17), less than Replimune Group, Inc. (13.46), greater than Nuvectis Pharma, Inc. (3.17), greater than Lyra Therapeutics, Inc. (3.60), less than Kronos Bio, Inc. (8.49), less than Gossamer Bio, Inc. (8.21), greater than ERYTECH Pharma S.A. (0), greater than Aptorum Group Limited (1.18), greater than Unicycive Therapeutics, Inc. (3.37), greater than Armata Pharmaceuticals, Inc. (0.25), greater than CytomX Therapeutics, Inc. (1.00), less than Instil Bio, Inc. (15.06), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.74),
Company | Current Ratio | Market cap |
---|---|---|
4.28 | $24.78M | |
10.93 | $513.64M | |
20.37 | $1.97B | |
9.58 | $40.82M | |
4.82 | $4.17M | |
0.66 | $711.28K | |
0.48 | $1.90K | |
2.17 | $31.26M | |
13.46 | $708.49M | |
3.17 | $115.27M | |
3.60 | $17.85M | |
8.49 | $59.36M | |
8.21 | $205.87M | |
0 | $47.38M | |
1.18 | $15.65M | |
3.37 | $33.41M | |
0.25 | $84.31M | |
1.00 | $93.74M | |
15.06 | $92.68M | |
15.33 | $8.20M | |
2.68 | $71.07M | |
2.74 | $107.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Surrozen, Inc.'s Current Ratio?
How is the Current Ratio calculated for Surrozen, Inc. (SRZN)?
What is the highest Current Ratio for Surrozen, Inc. (SRZN)?
What is the 3-year average Current Ratio for Surrozen, Inc. (SRZN)?
What is the 5-year average Current Ratio for Surrozen, Inc. (SRZN)?
How does the current Current Ratio for Surrozen, Inc. (SRZN) compare to its historical average?